SixOne Solutions is developing first in class products for treating metastatic breast cancer. Their products address a novel target, Eya/Six1 not targeted by current cancer drugs.

Research Grants 1 show all


$292.8K
2013

Contact Information

Overview

Total FundingEmployeesLast Funding DateStatus
1-10Operating